L. G. Conde

Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON).

C. Gessner, R. V. van Zyl-Smit, J. Maspero, 2020, Respiratory medicine.

Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma

M. Hyland, O. Spranger, M. Morais‐Almeida, 2018, ERJ Open Research.

Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma.

W. Busse, M. Humbert, S. Holgate, 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials

Lawrence A Leiter, U. Landmesser, F. Raal, 2022, Cardiovascular drugs and therapy.

Smoking asthmatics, a neglected large phenotype of asthmatic patients

M. Hyland, O. Spranger, A. Lindberg, 2019 .

Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11

Lawrence A Leiter, U. Landmesser, F. Raal, 2023, American journal of preventive cardiology.

Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials.

L. G. Conde, Ulf Landmesser, Lawrence A. Leiter, 2023, Atherosclerosis.

Estimating potential cardiovascular health benefits of improved population level control of LDL cholesterol through a twice-yearly siRNA-based approach: A simulation study of a health-system level intervention.

L. G. Conde, Ulf Landmesser, R. S. Wright, 2024, Atherosclerosis.